GE, IntrinsiQ Link Oncology Data in EMRs

May 31, 2007 - GE Healthcare today announced a collaboration with IntrinsiQ LLC, a leading provider of cancer care software solutions, to seamlessly connect a cancer patient’s team of clinicians by providing oncology clinical information within that patient’s electronic medical record (EMR). The partnership will be unveiled this week at the 43rd annual meeting of the American Society of Clinical Oncology in Chicago.
IntrinsiQ’s IntelliDose software fully automates the complex process of chemotherapy order entry and minimizes the potential for error by producing legible, complete and electronically checked orders. Interfacing these capabilities with GE’s Centricity Electronic Medical Record solution will help provide users with information about patients undergoing chemotherapy, including drug administration records and nurse notes.
Administration of chemotherapy requires precision and accuracy in a busy clinical setting, and studies have shown that chemotherapy errors can be traced to a variety of issues related to human error, procedural flaws and lack of standardization. IntrinsiQ’s technology is designed to help automate this process, while offering tools for error checking.